Tag Archives: Travecta Therapeutics

BIOTECH

Travecta Therapeutics Announces it has Closed its Oversubscribed Series A Round at $27 Million

NEW YORK and SINGAPORE – June 11, 2020 – Travecta Therapeutics, a biopharmaceutical company pioneering...

Read more

BIOTECH

Travecta Therapeutics Secures $15 Million in Financing

NEW YORK and SINGAPORE – May 12, 2020 – Travecta Therapeutics, a biopharmaceutical company developing...

Read more

EVENTS

Ventures Day Singapore 2020: Post-event highlights

WE HAD ANOTHER SUCCESSFUL VENTURES DAY IN SINGAPORE. Following our three successful past events –...

Read more

EVENTS

SPRIM’s Quarterly Ventures Day Meeting in New York

SPRIM, in partnership with Tikehau Capital, is hosting its quarterly Ventures Day meeting on April 24, and...

Read more

EVENTS

TKS 1 Investor Day 2019 in Singapore: Post Event Highlights

WE HAD A SUCCESSFUL TKS 1 INVESTOR DAY IN SINGAPORE. Following a successful Ventures Day...

Read more